A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma
Pavlos Msaouel, Randy F. Sweis, Manojkumar Bupathi, Elisabeth I. Heath, Oscar B. Goodman, Christopher Hoimes, Matthew I. Milowsky, Nancy B. Davis, Arash Rezazadeh Kalebasty, Joel Picus, David R. Shaffer, Shifeng Mao, Nabil Adra, Jeffrey T. Yorio, Sunil Gandhi, Petros Grivas, Arlene O. Siefker‐Radtke, Rui Yang, Lisa Latven, Peter Olson, Curtis D. Chin, Hirak Der‐Torossian, Amir Mortazavi, Gopa Iyer
Topics & Concepts
MedicineMetastatic Urothelial CarcinomaNivolumabOncologyUrothelial carcinomaMetastatic carcinomaInternal medicineCarcinomaImmunotherapyCancerBladder cancerPhagocytosis and Immune RegulationBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor Research